News | December 29, 2020

Top News Stories in 2020 From the European Society of Cardiology

ESC press releases that made the most headlines

Coffee and tea are good for your heart, heart healthy. Top News Stories in 2020 From the European Society of Cardiology

December 29, 2020 — Here is a list of the top 10 news stories from the European Society of Cardiology (ESC) in 2020 that generated the most media coverage worldwide.

ESC said COVID-19 has dominated the news this year. Nevertheless, cardiovascular disease remains the world’s leading cause of death. Lifestyle issues were popular in 2020, as reflected in the latest science from ESC journals and ESC Congress. New treatments made headlines, as did the ESC’s first recommendations on sports and physical activity in people with heart disease.

The top 10 ESC news stories were:

1. Tea drinkers live longer (European Journal of Preventive Cardiology)

2. Burnout linked with irregular heartbeat (European Journal of Preventive Cardiology)

3. How to make the healthiest coffee during COVID-19 lockdown (European Journal of Preventive Cardiology)

4. Chocolate is good for the heart (European Journal of Preventive Cardiology)

5. Long naps may be bad for health (ESC Congress 2020)

6. Belly fat linked with repeat heart attacks (European Journal of Preventive Cardiology)

7. DAPA-CKD trial meets primary endpoint in patients with chronic kidney disease (ESC Congress 2020 Hot Line)

8. EMPEROR-Reduced meets primary endpoint in heart failure with reduced ejection fraction (ESC Congress 2020 Hot Line)

9. Body mass index is a more powerful risk factor for diabetes than genetics (ESC Congress 2020)

10. Can people with heart disease exercise safely? (ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease; ESC Congress 2020)

 

Related Content:

Top 25 Stories in Cardiology in 2020

Top 25 Cardiology Videos on DAIC in 2020

Video Demonstrations of How Cardiovascular Technology Works

Find all DAIC videos


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now